THAR Tharimmune, Inc.
Healthcare$3.54+6.63%ClosedMarket Cap: $139.9M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.56
P/S
0.00
EV/EBITDA
-1.26
DCF Value
$0.50
FCF Yield
-17.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-36.9%
ROA
-13.8%
ROIC
-8.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-36.9M | $-47.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-13.6M | $-29.4M | $— | — |
| FY null | $0.00 | NaN% | $-20.1M | $-35.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.1M | $-2.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-1.9M | $-1.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.5M | $-2.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.8M | $-3.8M | $— | — |
| FY null | $0.00 | NaN% | $-12.4M | $-12.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.9M | $-3.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.4M | $-2.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.3M | $-2.3M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-2.5M | $-2.5M | $-3.16 | — |